Apr. 14, 2016—An international research team that included scientists from Vanderbilt University Medical Center has found a novel way to counteract obesity in mice — by stimulating the growth of blood vessels in fat tissue.
Apr. 4, 2016—John T. Wilson, assistant professor of chemical and biomolecular engineering, has received an NSF Faculty Early Career Development award. The five-year, $500,000 grant will allow him to develop new synthetic materials for “encoding” immunological messages and tightly regulating their delivery to the organs, cells and pathways of the immune system.
Apr. 4, 2016—Undergraduates taking Amanda Lowery’s Material Manipulations course have redesigned a toy car so a two-year-old with cerebral palsy can drive it.
Monroe Carell Jr. Children’s Hospital at Vanderbilt and Ryan Seacrest Foundation Open Seacrest Studios, a New Multimedia Broadcast Studio
Mar. 18, 2016—Taylor Swift Surprises Patients for the First Broadcast with Seacrest Monroe Carell Jr. Children’s Hospital at Vanderbilt, in partnership with the Ryan Seacrest Foundation (RSF), today celebrated the opening of a new state-of-the-art, multimedia broadcast studio, named Seacrest Studios, inside Children’s Hospital. The launch of Seacrest Studios at Children’s Hospital marks the 10th broadcast media...
Mar. 17, 2016—Researchers at Vanderbilt University Medical Center have “turned back the clock” in a mouse model of metaplasia — precancerous stomach lesions — raising hopes that gastric cancer, a worldwide scourge that’s rising in the United States, can be prevented.
Mar. 17, 2016—Since 1961, the Eye Bank Association of America has provided donors for more than 1.5 million corneal transplants nationwide. And for nearly 25 years, the group has celebrated corneal transplant recipients, promoted awareness of the need to donate and recognized donors and families during National Eye Donor Month in March.
Mar. 10, 2016—The U.S. Food and Drug Administration has given clearance to market and sell the powered lower-limb exoskeleton created by a team of Vanderbilt engineers and commercialized by the Parker Hannifin Corporation for both clinical and personal use in the United States.
Mar. 7, 2016—Researchers at Vanderbilt University Medical Center have isolated human antibodies against a type of bird flu that has killed more than 200 people in China since 2012 and which may pose a worldwide pandemic threat.
Mar. 3, 2016—For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient’s own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system.